2005
DOI: 10.3177/jnsv.51.460
|View full text |Cite
|
Sign up to set email alerts
|

Glucosyl Hesperidin Lowers Serum Triglyceride Level in Hypertriglyceridemic Subjects through the Improvement of Very Low-Density Lipoprotein Metabolic Abnormality

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

3
54
3

Year Published

2006
2006
2023
2023

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 67 publications
(61 citation statements)
references
References 40 publications
3
54
3
Order By: Relevance
“…The accumulation of these TG-rich lipoproteins in serum is considered to be caused by an imbalance of the synthesis and catabolism of VLDL, namely, VLDL metabolic abnormality (12)(13)(14). In the previous clinical study, we have found that G-hesperidin administration reduced serum VLDL and remnant lipoproteins in the hypertriglyceridemic subjects ( 11 ). From this result, it is suggested that the TG-lowering effect of G-hesperidin is due to the improvement of VLDL metabolic abnormality.…”
Section: Discussionmentioning
confidence: 95%
See 2 more Smart Citations
“…The accumulation of these TG-rich lipoproteins in serum is considered to be caused by an imbalance of the synthesis and catabolism of VLDL, namely, VLDL metabolic abnormality (12)(13)(14). In the previous clinical study, we have found that G-hesperidin administration reduced serum VLDL and remnant lipoproteins in the hypertriglyceridemic subjects ( 11 ). From this result, it is suggested that the TG-lowering effect of G-hesperidin is due to the improvement of VLDL metabolic abnormality.…”
Section: Discussionmentioning
confidence: 95%
“…In addition, G-hesperidin administration significantly decreased an elevated serum apolipoprotein B (apo B) level in hypertriglyceridemic subjects ( 11 ). It has been demonstrated that apo B forms VLDL by complexing with TG and cholesteryl ester (CE) in hepatocytes and is secreted from the liver (15)(16)(17)(18).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…6,31) In a human study, no clinical changes related to 24-week administration of G-hesperidin were observed in subjects. 32) Hence the safety of G-hesperidin is considered to be comparable to that of hesperidin. Additionally, we observed that the metabolites, such as hesperetin, hesperidin, and their conjugates, were rapidly excreted in rat urine after administration of G-hesperidin (Fig.…”
Section: Discussionmentioning
confidence: 99%
“…Hesperidin is a flavone abundantly found in citrus fruit peel. Glucosyl hesperidin has been shown to reduce serum TG in several animal models (5,6) and in subjects with hypertirglyceridemia (7,8). Glucosyl hesperidin plus caffeine is effective for controlling obesity mediated by the inhibition of hepatic lipogenesis (9).…”
Section: Discussionmentioning
confidence: 99%